GeoVax Labs enters ATM equity offering agreement for up to $6.529M

GeoVax Labs, Inc.

Company may sell up to $6,529,000 of common stock at market prices via H.C. Wainwright as sales agent.
Wainwright receives 3% commission on gross proceeds; company also reimburses up to $50,000 in expenses.
Sales will be made under existing effective S-3 shelf registration (File No. 333-252437).
Agreement dated July 18, 2023; no obligation to sell any shares.
Proceeds used for general corporate purposes; potential dilution for existing shareholders.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

GeoVax Labs, Inc. entered into At The Market Offering Agreement with H.C. Wainwright & Co., LLC valued at up to $6,529,000 (effective 2023-07-18).

Action: entry
Agreement: atm program
Counterparty: H.C. Wainwright & Co., LLC
Value: up to $6,529,000
Effective: 2023-07-18

Exact text from the filing

On July 18, 2023, GeoVax Labs, Inc. (the “Company”) entered into an At The Market Offering Agreement (the “ATM Agreement”) with H.C. Wainwright & Co., LLC (“Wainwright”), as sales agent, pursuant to which we may offer and sell, from time to time, through Wainwright shares of our common stock, $0.001 par value per share.

View on SEC.gov

25 material agreements filed in the last 30 days. Browse all material agreements →

GeoVax Labs, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-23-020163

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.